• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20010 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Results of research about HTA: therapeutic procedures in oncology. IPE-02/32 (Public report)
1999     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Guide for performing health technology assessment reports. IPE-99/19 (Public report)
1996     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Catalogue 1996: Reports of Health Technology Assessment and Clinical Practice Guidelines IPE-CAT-96/06 (Public report)
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Stereotactic radiosurgery: indications and Spanish situation. IPE-97/12 (Public report)
2013     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) PET in non-neurological clinical oncology. IPE-97/11 (Public report)
2014     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Stent-grafts for abdominal aortic aneurysms (AAA). IPE-97/13 (Public report)
2014     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [EndoBarrier® evaluation device for the treatment of morbid obesity with or without diabetes mellitus type II]
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) The effectiveness, safety and efficiency of endovascular stent grafts to repair thoracic aortic aneurysms. CISNS-01/06 (Public report)
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost studies of type 2 diabetes: a review of literature]
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Indications and contraindications of the liver transplantation and retransplantation - expert panel. IPE-95/04 (Public report)
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Pathological complications of menopause. IPE-95/03 (Public report)
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography (PET) in cardiology. IPE-95/e (Public report)
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Studies and scales used in technologies within the orthoprosthetic benefits. IPE-02/33 (Public report)
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Post-polio syndrome: revision of the literature, situation in Spain and possible performance lines (public report). CISNS-02/07
2003     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Early warning system for new and emerging health technologies. The SINTESIS - new technologies project. IPE-03/38 (Public report)
2003     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Review of primary care interventions to improve the quality of chronic disease management. IPE-03/39 (Public report)
2003     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Efficacy, effectiveness and cost-effectiveness of interventions for smoking cessation IPE-03/40 (Public report)
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Systematic review of the effectiveness and safety of endovascular treatment of thoracic aortic diseases
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Monitored use of endovascular treatment of abdominal aortic aneurysms using endovascular grafts IPE-05/44 (Public report)
2006     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Techniques and technologies in medical hydrology and hydrotherapy. IPE-06/50
2007     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) OECD guidelines for quality assurance in molecular genetic testing (Spanish version). IPE-07/53
2007     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Health impact assessment and environment IPE-07/52
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Breast cancer screening through mammography. IPE-95/05 (Public report)
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Long-term oxygen therapy and mechanical ventilation at home. IPE-95/01 (Public report)
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Epidemiological assessment of health technologies. IPE-95/02 (Public report)
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Cochlear implants. IPE-95/d (Public report)
1996     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Assessment of the different types of dialyzer membranes for ESRD. IPE-96/07 (Public report)
1996     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Endovascular stents for the treatment of peripheral arterial disease for lower limbs. IPE-96/09 (Public report)
1996     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Surgery in benign hypertrophy of the prostate. Standards of appropriate use. IPE-96/08 (Public report)
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Efficacy of serogroup C meningococcal polysaccharide vaccine. IPE-97/10 (Public report)
2006     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Use of FDG-PET in clinical situations not addressed in the monitorized use of this technology. IPE-06/49
1998     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Effectiveness and safety of penile prosthesis. IPE-98/15 (Public report)
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Sex change surgery - expert panel. IPE-02/i
2010     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost-utility analysis of pharmacological treatments for the prevention of bone fractures in osteoporotic post-menopausal Spanish women]
2003     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Supervised use of artificial anal sphincter - database and technology assessment. IPE-03/k
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2003     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Disease management - non-systematic review. IPE-03/l
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in mental health (Telepsychiatry)]
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Physical disease in schizophrenia: systematic review and analysis of hospital records]
2004     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services.
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Transient elastography (Fibroscan) for the diagnosis of liver fibrosis: a systematic review and meta-analysis]
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2004     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) PET-CT: indications, systematic review and meta-analysis IPE-04/41 (Public report)
2010     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Decentralized cooperation for development in health and environment: Assessment of barriers and opportunities]
2010     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Rapid systematic review on radiotherapy in lung cancer]
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Monitorized use of 18FDG positron emission tomography
1999     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Intraoperative radiation therapy. IPE-99/22 (Public report)
2008     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Definition of health benefits packages in some reference countries with advanced health systems
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Assessment of the effectiveness of health promotion and disease prevention technologies. IPE-02/36 (Public report)
1999     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Catalogue 2000: Reports and publications from Spanish Health Technology Assessment Agencies. IPE-CAT-99/20 (Public report)
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography (PET) with 18FDG on clinical oncology. IPE-01/30 (Public report)
2011     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost-utility analysis of the introduction of universal infant rotavirus vaccination in Spain]
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Effectiveness of special dressings in the treatment of pressure and leg ulcers. IPE-01/28 (Public report)
2011     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Safety and efficacy of metformin in improving clinical, hormonal and metabolic features of polycystic ovary syndrome. Systematic review and meta-analysis ]
2011     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) A framework for science advice on health: principles and guidelines
2012     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [1st Expert Panel on viper venomous bite in Spain]
2012     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Transurethral needle ablation (TUNA) in the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis
1998     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ultrasonography in primary health care. IPE-98/16 (Public report)
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Analysis of the situation of health care involved in human assisted reproduction in the Canary Islands: needs, requests and organization proposal for all the region. IPE-01/h (Internal report)
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Analysis of the 1997 Spanish National Health Survey. IPE-01/29 (Public report)
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Hospital management of ischemic heart disease in Spain. Analysis of the current context. IPE-01/31 (Public report)
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Utilization of information and communication technology in managing chronic diseases: a systematic review IPE-05/45 (Public report)
2011     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Effectiveness and safety of electrochemotherapy tumor treatment: Systematic review and meta-analysis]
2008     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Assessment of interventions for the reduction of infant and maternal mortality in developing countries
2022     Agency for Care Effectiveness (ACE) Revivent TC transcatheter ventricular enhancement system for ischemic heart failure
2022     Agency for Care Effectiveness (ACE) Vagus nerve stimulation with the VITARIA System for heart failure with reduced ejection fraction
2022     Agency for Care Effectiveness (ACE) Caption guidance to guide image acquisition in point-of-care echocardiography for patients with cardiovascular disease
2022     Agency for Care Effectiveness (ACE) The PrecivityAD test for the prognosis of Alzheimer's disease
2022     Agency for Care Effectiveness (ACE) Artificial intelligence and its clinical applications
2022     Agency for Care Effectiveness (ACE) 3D printing and its clinical applications
2022     Agency for Care Effectiveness (ACE) Overview of clinical applications of telemedicine
2022     Agency for Care Effectiveness (ACE) Bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears
2018     Agency for Care Effectiveness (ACE) 18F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET-CT) for oncological indications
2019     Agency for Care Effectiveness (ACE) Video capsule endoscopy for diagnosing obscure gastrointestinal bleeding
2022     Agency for Care Effectiveness (ACE) Percutaneous vertebral augmentation systems for treating patients with vertebral compression fractures
2019     Agency for Care Effectiveness (ACE) Ambulatory sleep study for diagnosing obstructive sleep apnoea
2022     Agency for Care Effectiveness (ACE) Continuous subcutaneous insulin infusion therapy for treating type 1 diabetes
2020     Agency for Care Effectiveness (ACE) Acupuncture for adults with low back pain and neck pain
2021     Agency for Care Effectiveness (ACE) MRI-US fusion targeted biopsy for diagnosis of prostate cancer
2021     Agency for Care Effectiveness (ACE) Transcatheter mitral valve leaflet repair for patients with mitral regurgitation
2021     Agency for Care Effectiveness (ACE) Transcatheter aortic valve implantation (TAVI) for patients with symptomatic severe aortic stenosis
2021     Agency for Care Effectiveness (ACE) Photodynamic therapy for treating non-melanoma skin tumours
2021     Agency for Care Effectiveness (ACE) Cochlear implants for treating adults with single-sided deafness (SSD)
2021     Agency for Care Effectiveness (ACE) Antibacterial envelope for the prevention of cardiac implantable electronic device-related infections
2021     Agency for Care Effectiveness (ACE) Repetitive transcranial magnetic stimulation for adults with treatment resistant major depressive disorder
2022     Agency for Care Effectiveness (ACE) Bone conduction hearing implants for patients with conductive or mixed hearing loss
2022     Agency for Care Effectiveness (ACE) Active middle ear implants for patients with hearing loss
2022     Agency for Care Effectiveness (ACE) Bone conduction hearing implants for patients with single sided deafness
2022     Agency for Care Effectiveness (ACE) Coronary intravascular lithotripsy for patients with severely calcified, stenotic de novo coronary artery
2021     Agency for Care Effectiveness (ACE) Golimumab for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis
2017     Agency for Care Effectiveness (ACE) Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours
2022     Agency for Care Effectiveness (ACE) Denosumab for treating osteoporosis and glucocorticoid-associated bone loss
2017     Agency for Care Effectiveness (ACE) Gliclazide for the treatment of type 2 diabetes mellitus
2017     Agency for Care Effectiveness (ACE) Ustekinumab for the treatment of chronic plaque psoriasis and psoriatic arthritis
2020     Agency for Care Effectiveness (ACE) Sodium-glucose co-transporter 2 (SGLT2) inhibitors for type 2 diabetes mellitus
2022     Agency for Care Effectiveness (ACE) Non-vitamin K antagonist oral anti-coagulation agents (NOACs) for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation